@article{e8ebf20ed1e04623a6971ff920db3d12,
title = "Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity",
keywords = "antibodies response, multiple myeloma, rasburicase, tumor lysis syndrome",
author = "Riccardo Moia and Elena Boggio and Luca Gigliotti and Elena Cris{\`a} and \{De Paoli\}, Lorenzo and \{Margiotta Casaluci\}, Gloria and Roberta Rolla and Andrea Patriarca and Gianluca Gaidano and Umberto Dianzani and Riccardo Bruna",
note = "Funding Information: This work was supported by Molecular bases of disease dissemination in lymphoid malignancies to optimize curative therapeutic strategies (5 × 1000 No. 21198) and IG 20714, Associazione Italiana per la Ricerca sul Cancro Foundation, Milan, Italy; Progetti di Rilevante Interesse Nazionale (PRIN), (2015ZMRFEA), Rome, Italy; Fondazione Cariplo (2017‐0535), Milan, Italy; Partially founded by the AGING Project—Department of Excellence—DIMET, Universit{\`a} del Piemonte Orientale, Novara, Italy; and Ricerca Finalizzata 2018 (project RF‐2018‐12365790), MoH, Rome, Italy. ",
year = "2020",
month = apr,
day = "1",
doi = "10.1002/hon.2700",
language = "English",
volume = "38",
pages = "204--206",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "John Wiley and Sons Ltd",
number = "2",
}
